---
document_datetime: 2023-09-21 18:10:35
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/levetiracetam-hospira-epar-all-authorised-presentations_en.pdf
document_name: levetiracetam-hospira-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7698554
conversion_datetime: 2025-12-20 17:41:27.774997
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) Number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/13/889/001   | Levetiracetam Hospira   | 100 mg/ml   | Concentrate for solution for infusion   | Intravenous use   | vial (glass)   | 5 ml   | 10 vials   |
|-------------------|-------------------------|-------------|-----------------------------------------|-------------------|----------------|--------|------------|
| EU/1/13/889/002   | Levetiracetam Hospira   | 100 mg/ml   | Concentrate for solution for infusion   | Intravenous use   | vial (glass)   | 5 ml   | 25 vials   |